Skip to main content
Erschienen in: Journal of Hematology & Oncology 1/2017

Open Access 01.12.2017 | Erratum

Erratum to: Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia

verfasst von: Chau-To Kwok, Amy D. Marshall, John E. J. Rasko, Justin J. L. Wong

Erschienen in: Journal of Hematology & Oncology | Ausgabe 1/2017

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The online version of the original article can be found under doi:10.​1186/​s13045-017-0410-6.

Erratum

The original article [1] contained an error whereby the formatting of Table 1 was not presented correctly; this error has now been corrected.
Table 1
Clinical and molecular characteristics of TCGA AML patients according to the mutation and/or copy number variation status of genes encoding m6A regulatory enzymes
 
Mutation and/or CNV
CNV onlya
Mutation
 
Yes (n = 23)
No (n = 168)
P
Yes (n = 18)
No (n = 168)
P
Yes (n = 5)
No (n = 186)
P
Age
  
0.083
  
0.193
  
0.205
Median (range)
65 (18–81)
57 (21–88)
 
62.5 (18–81)
57 (21–88)
 
65 (45–76)
57.5 (18–88)
 
Sex, no. (%)
  
0.123
  
0.321
  
0.376
Male
16 (8.4)
87 (45.5)
 
12 (6.5)
87 (46.8)
 
4 (2.1)
99 (51.8)
 
Female
7 (3.7)
81 (42.4)
 
6 (3.2)
81 (43.5)
 
1 (0.5)
87 (45.5)
 
BM blast
  
0.072
  
0.038
  
0.915
Median % (range)
60 (30–97)
73 (30–100)
 
54 (30–97)
73 (30–100)
 
75 (33–90)
72 (30–100)
 
WBC, ×103/mm3
  
0.084
  
0.047
  
0.889
Median (range)
5.4 (0.7–202.7)
17.5 (0.4–298.4)
 
5.2 (2.3–101.3)
17.45 (0.4–298.4)
 
14.5 (2.3–101.3)
15.6 (0.4–298.4)
 
Cytogenetic risk, no. (%)
  
<0.0001
  
<0.0001
  
0.483
Favorable
0 (0)
37 (19.4)
 
0 (0)
37 (19.9)
 
0 (0)
37 (19.4)
 
Intermediate
4 (2.1)
105 (55)
 
1 (0.5)
105 (56.5)
 
3 (1.6)
106 (55.5)
 
Unfavorable
19 (9.9)
21 (11)
 
17 (9.1)
21 (11.3)
 
2 (1)
38 (19.9)
 
Missing data
0 (0)
5 (2.6)
 
0 (0)
5 (2.6)
 
0 (0)
5 (2.6)
 
Mutation, no./total no. (%)
 FLT3
1/23 (4.3)
53/168 (31.5)
0.005
0/18 (0)
53/168 (31.5)
0.002
1/5 (20)
53/186 (28.4)
1.000
 NPM1
1/23 (4.3)
51/168 (30)
0.006
0/18 (0)
51/168 (30.3)
0.004
1/5 (20)
51/186 (27.4)
1.000
 DNMT3A
4/23 (17.4)
43/168 (25.6)
0.453
2/18 (11.1)
43/168 (25.6)
0.249
2/5 (40)
45/186 (24.2)
0.598
 IDH1 or IDH2
1/23 (4.3)
34/168 (20.2)
0.084
0/18 (0)
34/168 (20.2)
0.048
1/5 (20)
34/186 (18.3)
1.000
 NRAS or KRAS
3/23 (13)
20/168 (11.9)
0.744
3/18 (16.7)
20/168 (11.9)
0.471
0/5 (0)
23/186 (12.4)
1.000
 RUNX1
2/23 (8.7)
17/168 (10.1)
1.000
0/18 (0)
17/168 (10.1)
0.380
2/5 (40)
17/186 (9.1)
0.078
 TET2
1/23 (4.3)
15/168 (8.9)
0.698
1/18(5.6)
15/168 (8.9)
1.000
0/5 (0)
16/186 (8.6)
1.000
 TP53
15/23 (65.2)
1/168 (0.6)
<0.0001
13/18 (72.2)
1/168 (0.6)
<0.0001
2/5 (40)
14/186 (7.5)
0.057
 CEBPA
2/23 (8.7)
10/168 (6.0)
0.641
2/18 (11.1)
10/168 (6.0)
0.327
0/5 (0)
12/186 (6.5)
1.000
 WT1
0/23 (0)
12/168 (7.1)
0.366
0/18 (0)
12/168 (7.1)
0.610
0/5 (0)
12/186 (6.5)
1.000
 PTPN11
2/23 (8.7)
6/168 (3.6)
0.248
2/18 (11.1)
6/168 (3.6)
0.175
0/5 (0)
8/186 (4.3)
1.000
 KIT
1/23 (4.3)
6/168 (3.6)
0.599
0/18 (20)
6/168 (3.6)
1.000
1/5 (20)
6/186 (3.2)
0.172
Significant P values are in bold
CNV copy number variation, BM bone marrow, WBC white blood cell
aExcluding samples with m6A regulatory gene mutations
Furthermore, the error was mistakenly carried forward by the production team handling this article, and thus was not the fault of the authors.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Literatur
Metadaten
Titel
Erratum to: Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia
verfasst von
Chau-To Kwok
Amy D. Marshall
John E. J. Rasko
Justin J. L. Wong
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
Journal of Hematology & Oncology / Ausgabe 1/2017
Elektronische ISSN: 1756-8722
DOI
https://doi.org/10.1186/s13045-017-0419-x

Weitere Artikel der Ausgabe 1/2017

Journal of Hematology & Oncology 1/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.